1. Introduction
Incomplete anencephaly, also medically categorized under the broader term meroanencephaly, is a severe congenital anomaly characterized by the partial absence of the cranial vault and overlying skin, with some preservation of brain tissue. The bottom line up front is that this condition is a profound neural tube defect occurring early in embryonic development, which, while clinically distinct from classic total anencephaly due to the presence of some malformed brain structures, universally carries a grim prognosis and requires comprehensive obstetric and palliative management.
Neural tube defects represent a complex failure of the embryonic nervous system to close properly. Understanding the precise embryological timeline helps clarify why these defects occur before many women are even aware they are pregnant. Navigating a diagnosis of incomplete anencephaly involves detailed radiological assessment and requires profound clinical empathy, as the medical team supports the family through complex diagnostic and care decisions.
2. Embryological Origins
The human nervous system begins as a flat plate of cells known as the neural plate. During the third and fourth weeks of gestation, this plate folds inward to form a groove, and the edges of this groove eventually fuse to create a closed cylinder called the neural tube. This tube serves as the foundational structure for the brain and spinal cord.
Fusion of the neural tube does not happen all at once; it occurs at specific closure points, zipping upward toward the head and downward toward the tail. The cranial end, known as the anterior neuropore, is scheduled to close around the twenty-fifth day of embryonic life. When this specific closure process fails, the developing brain is left exposed to the amniotic fluid.
3. The Neural Tube Defect Spectrum
Neural tube defects encompass a broad spectrum of structural anomalies. At the caudal end of the spine, failure of closure results in spina bifida. At the cranial end, failures result in conditions ranging from exencephaly (exposed brain outside the skull) to classic anencephaly (absence of the forebrain and cranial vault).
Classic anencephaly is the most severe presentation at the cranial end, resulting in the total absence of the cerebrum and a flat, rudimentary base of the skull. The exposed neural tissue rapidly degenerates due to prolonged contact with amniotic fluid, leaving only a spongy mass of vascular tissue.
4. Defining Incomplete Anencephaly
Incomplete anencephaly (meroanencephaly) represents a clinical variation within this spectrum. In this specific presentation, the defect in the cranial vault (acrania) is present, but it does not encompass the entire cranium. Some rudimentary formation of the skull base and fragments of the cranial vault remain.
Because the skull defect is partial, the destruction of the underlying brain tissue is also variable. A remnant of the brainstem, midbrain, and even parts of the diencephalon may be preserved, covered by a distinct vascular and fibrotic tissue layer known as the area cerebrovasculosa. Despite this partial preservation, the cerebral hemispheres fail to develop normally.
5. Genetic and Environmental Factors
The exact cause of neural tube defects is multifactorial, involving a complex interplay of genetic predispositions and environmental exposures. There is a documented familial recurrence risk; parents who have had one child with a neural tube defect carry a higher risk in subsequent pregnancies, indicating underlying genetic variations affecting folate metabolism or embryonic cellular signaling.
Environmental teratogens also play a significant role. Maternal pre-gestational diabetes, obesity, and the use of certain anticonvulsant medications (such as valproic acid) during early pregnancy have been clinically proven to disrupt normal neural tube closure. Furthermore, maternal hyperthermia during the critical third and fourth weeks of gestation is a known risk factor.
6. Role of Folic Acid
The most critical and well-established environmental factor in the development of these defects is the maternal level of folic acid (Vitamin B9). Folic acid is essential for DNA synthesis and rapid cell division, both of which are required in immense quantities during the rapid closure of the neural tube.
A deficiency in folate during the peri-conceptional period prevents the cellular proliferation necessary to seal the neural folds. Clinical data demonstrates that adequate maternal supplementation of folic acid starting at least one month before conception and continuing through the first trimester reduces the incidence of all neural tube defects, including incomplete anencephaly, by a significant percentage.
7. Prenatal Screening
Because neural tube defects occur so early in gestation, modern obstetric care relies heavily on proactive prenatal screening. The initial screening often involves a maternal serum blood test performed between the fifteenth and twentieth weeks of pregnancy, analyzing specific biochemical markers.
The primary marker of interest is maternal serum alpha-fetoprotein. Alpha-fetoprotein is a protein produced by the fetal liver. In a healthy pregnancy, small amounts cross the placenta into the mother’s blood. However, when the fetus has an open neural tube defect, large amounts of this protein leak directly from the exposed fetal tissue into the amniotic fluid and subsequently into the maternal circulation.
8. Ultrasound Diagnosis
Elevated levels of maternal serum alpha-fetoprotein prompt immediate investigation with high-resolution fetal ultrasound. Ultrasound is the definitive imaging modality for diagnosing incomplete anencephaly. A skilled sonographer can identify cranial vault defects as early as the late first trimester, though visualization becomes much clearer in the second trimester.
The classic sonographic findings include the absence of a normal, rounded skull contour. In incomplete anencephaly, the sonographer will document the extent of the missing calvarium and the presence of any disorganized neural tissue or the area cerebrovasculosa floating in the amniotic fluid. This is sometimes described as the “Mickey Mouse” or “frog-like” sign due to the prominent, unprotected fetal orbits.
9. Amniocentesis and Alpha-Fetoprotein
If ultrasound findings are ambiguous, or if additional genetic testing is required to rule out associated chromosomal syndromes (such as Trisomy 13 or 18), an amniocentesis may be performed. A thin needle is used to extract a small sample of amniotic fluid under ultrasound guidance.
The amniotic fluid is tested for both alpha-fetoprotein and acetylcholinesterase. Acetylcholinesterase is an enzyme specific to neural tissue. The presence of both elevated alpha-fetoprotein and positive acetylcholinesterase in the amniotic fluid confirms an open neural tube defect with absolute certainty, separating it from other causes of elevated serum proteins.
| Diagnostic Test | Optimal Timing | Findings Indicating Neural Tube Defect |
|---|---|---|
| Maternal Serum Alpha-Fetoprotein | 15-20 weeks gestation | Significantly elevated levels in maternal blood |
| High-Resolution Ultrasound | 11-20 weeks gestation | Visible absence of cranial vault, exposed neural tissue |
| Amniocentesis | 15+ weeks gestation | Elevated AFP and presence of acetylcholinesterase in fluid |
10. Clinical Manifestations
Infants born with incomplete anencephaly exhibit profound neurological deficits. Because the brainstem may be partially preserved, basic autonomic functions such as spontaneous breathing, heart rate, and simple reflex responses to tactile stimulation may be present at birth.
However, the absence or severe malformation of the cerebral cortex means that higher neurological functions, consciousness, pain perception, and complex sensory processing are absent. Associated physical anomalies, such as cleft palate, folding of the ears, and structural defects of the cervical spine, are also frequently observed.
11. Differential Diagnosis
The clinician must distinguish incomplete anencephaly from other severe cranial anomalies. Encephalocele involves the herniation of brain tissue through a specific, closed defect in the skull, usually covered by skin. Acrania is the complete absence of the skull bones but with a completely formed, albeit unprotected, brain, which eventually degenerates into anencephaly.
Amniotic band syndrome can occasionally mimic cranial defects if a fibrous band wraps around the developing head, causing an amputation or disruption of the skull and brain tissue. Accurate differentiation is important for counseling the family on recurrence risks, as amniotic band syndrome is typically a random event, while neural tube defects carry a familial recurrence risk. Identifying these structural anomalies requires precision comparable to assessing a congenital spine malformation.
12. Obstetric Management
Upon receiving a diagnosis, obstetric management focuses on comprehensive patient counseling and maternal safety. Because the condition is uniformly lethal to the fetus, the medical team provides thorough, objective information regarding the prognosis.
Maternal health during the pregnancy must be monitored closely. Pregnancies affected by severe neural tube defects are at a higher risk for polyhydramnios (an excessive accumulation of amniotic fluid) because the fetus often lacks the swallowing reflex necessary to regulate fluid levels. This can lead to maternal discomfort, respiratory compromise, and preterm labor.
13. Palliative Care Considerations
If the pregnancy continues to term, pediatric and neonatal palliative care teams become heavily involved. The medical consensus is that aggressive resuscitation, intubation, or surgical intervention is medically futile and ethically inappropriate, as these measures cannot alter the underlying neurological absence.
Care focuses entirely on comfort. The infant is kept warm, gently cleaned, and immediately placed in the arms of the parents. The nursing staff ensures that any visible defects are respectfully covered to allow the family to bond with their child in a calm, supportive environment for whatever time is available.
14. Psychological Support for Families
A diagnosis of incomplete anencephaly induces profound grief. The clinical environment must support the psychological and emotional well-being of the parents. Social workers, grief counselors, and pastoral care are integrated into the medical team early in the diagnostic process.
Families are guided through anticipatory grief and supported in making difficult decisions regarding the continuation of the pregnancy, labor and delivery planning, and eventual memory-making, such as taking photographs or collecting footprints, which are vital steps in the grieving process.
15. Future Pregnancy Planning
For parents planning future pregnancies, specialized pre-conceptional counseling is essential. Because there is a statistically increased recurrence risk for any neural tube defect in subsequent pregnancies, standard prenatal vitamin doses of folic acid are insufficient.
The clinical guideline mandates a prescription-strength dose of folic acid (typically four milligrams daily), starting at least one to three months before attempting to conceive and continuing through the first trimester. This targeted, high-dose supplementation significantly mitigates the recurrence risk.
16. Frequently Asked Questions (FAQ)
1. What is the difference between classic and incomplete anencephaly?
In classic anencephaly, almost the entire skull and forebrain are missing. In incomplete anencephaly, parts of the base of the skull and small fragments of brainstem tissue remain, though the higher brain functions are still absent.
2. Can this condition be fixed with fetal surgery?
No. While some neural tube defects like spina bifida can be operated on before birth to protect the spinal cord, incomplete anencephaly involves the failure of the brain to form properly. This missing tissue cannot be reconstructed.
3. Does taking folic acid guarantee this will not happen?
Folic acid is the single most effective way to prevent neural tube defects, reducing the risk significantly. However, because genetic factors also play a role, it cannot eliminate the risk entirely.
4. When can a doctor tell if a baby has this condition?
A skilled ultrasound technician can often detect severe cranial defects by the end of the first trimester (around 11 to 14 weeks), with a definitive diagnosis usually made during the anatomy scan between 18 and 20 weeks.
5. Is this condition painful for the baby?
Medical evidence indicates that because the cerebral cortex (the part of the brain responsible for perceiving pain and consciousness) does not develop, the infant cannot feel pain or suffer.
17. Bibliography
Disclaimer: The content is for informational purposes only and does not replace medical advice. Always consult your doctor for personalized treatment.
